Bookbuilding IPO | ₹[.] Cr | Listing at BSE SME |
Rednex Pharmaceuticals Ltd. has withdrawn its Initial Public Offer (IPO) documents filed with the exchange on December 30, 2025.
Rednex Pharmaceuticals Ltd. IPO was a Book Build Issue consisting solely of fresh issue of upto 0.27 crore equity shares.
The equity shares were proposed to be listed on the BSE SME. Hem Securities Ltd. was the book running lead manager and Bigshare Services Pvt.Ltd. was the registrar of the issue.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 27,36,000 shares (agg. up to ₹[.] Cr) |
| Fresh Issue | 27,36,000 shares (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 76,50,000 shares |
| Share Holding Post Issue | 1,03,86,000 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Tue, Sep 30, 2025 |
| Offer document withdrawn | Tue, Dec 30, 2025 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
Incorporated in 2020, Rednex Pharmaceuticals is a pharmaceutical manufacturing company, producing a wide range of medicines used across various therapeutic areas such as antibacterial, antifungal, antimalarial, pain relief, antacid, antiallergy, and more. The company also manufactures medicines for other companies under loan license and contract manufacturing arrangements.
Its manufacturing facility is located in Bavla, Ahmedabad, covering 9,212.63 sq. meters, and includes two separate manufacturing units:
The manufacturing facility is well equipped with modern automated machinery, in-house laboratories, and storage facilities for raw materials and finished goods. It also hold certifications such as FDCA License, WHO Certificate, ISO 9001:2015 (Quality Management), and ISO 14001:2015 (Environmental Management).
The company also work with third-party companies under loan license arrangements, allowing them to market products under their own brand names.
The company sells products in both the domestic and international markets. Currently, it export through local merchant exporters to several countries including Angola, Cameroon, Congo, Fiji, Iraq, Liberia, Nigeria, UAE, Zambia, and others.
As on June 30, 2025, the company had 146 permanent employees.
Competitive Strengths
Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 50.12 | 32.75 | 17.10 |
| Total Income | 46.12 | 24.48 | 1.72 |
| Profit After Tax | 4.26 | 1.93 | -0.93 |
| EBITDA | 9.21 | 4.57 | -0.69 |
| NET Worth | 9.47 | 5.21 | 3.27 |
| Reserves and Surplus | 5.22 | 0.96 | -0.98 |
| Total Borrowing | 19.14 | 19.22 | 10.35 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment in full or in part, of certain of our outstanding borrowings | 9.00 |
| 2 | Funding capital expenditure towards purchase of new machinery | 6.08 |
| 3 | Funding to meet Working Capital requirements | 15.00 |
| 4 | General Corporate Purpose |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 58.10% |
| ROCE | 23.29% |
| Debt/Equity | 2.02 |
| RoNW | 45.02% |
| PAT Margin | 9.31% |
| EBITDA Margin | 20.12% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 100% |
Lead Manager Reports
Rednex Pharmaceuticals IPO is a SME IPO of 27,36,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Rednex Pharmaceuticals IPO open and close dates are not available as of now.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Rednex Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Rednex Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Rednex Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Rednex Pharmaceuticals IPO dates are not announced. Please check back again after some time.
Rednex Pharmaceuticals IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Rednex Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Rednex Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Rednex Pharmaceuticals IPO allotment status.
The Rednex Pharmaceuticals IPO listing date is not yet announced. The tentative date of listing is .
